SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000914121-22-004094
Filing Date
2022-09-13
Accepted
2022-09-13 16:10:40
Documents
2
Group Members
DOUGLAS L. BRAUNSTEINHEC MANAGEMENT GP LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13DA hu58209545-sc13da.htm SC 13D/A 61408
2 SCHEDULE OF TRANSACTIONS EFFECTED DURING THE LAST 60 DAYS hu58209545-ex3.htm EX-3 7725
  Complete submission text file 0000914121-22-004094.txt   70796
Mailing Address C/O CADWALADER, WICKERSHAM & TAFT, LLP 200 LIBERTY STREET NEW YORK NY 10281
Business Address C/O CADWALADER, WICKERSHAM & TAFT, LLP 200 LIBERTY STREET NEW YORK NY 10281 (212) 521-8495
Hudson Executive Capital LP (Filed by) CIK: 0001652522 (see all company filings)

IRS No.: 472878186 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Subject) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92564 | Film No.: 221240854
SIC: 3826 Laboratory Analytical Instruments